Envestnet Portfolio Solutions Inc. Has $2.17 Million Holdings in STERIS plc (NYSE:STE)

Envestnet Portfolio Solutions Inc. decreased its position in STERIS plc (NYSE:STE - Free Report) by 27.7% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 9,559 shares of the medical equipment provider's stock after selling 3,654 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in STERIS were worth $2,167,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Park Edge Advisors LLC lifted its holdings in shares of STERIS by 1.0% in the first quarter. Park Edge Advisors LLC now owns 4,709 shares of the medical equipment provider's stock valued at $1,067,000 after purchasing an additional 47 shares in the last quarter. Citizens Financial Group Inc. RI lifted its stake in STERIS by 5.9% in the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after acquiring an additional 54 shares in the last quarter. Gallagher Fiduciary Advisors LLC lifted its stake in STERIS by 3.3% in the 4th quarter. Gallagher Fiduciary Advisors LLC now owns 1,970 shares of the medical equipment provider's stock worth $405,000 after acquiring an additional 63 shares in the last quarter. West Coast Financial LLC boosted its position in STERIS by 3.9% during the 1st quarter. West Coast Financial LLC now owns 1,658 shares of the medical equipment provider's stock worth $376,000 after acquiring an additional 63 shares during the period. Finally, Oregon Public Employees Retirement Fund boosted its position in STERIS by 0.8% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 8,459 shares of the medical equipment provider's stock worth $1,739,000 after acquiring an additional 65 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on STE. Stephens reissued an "overweight" rating and issued a $250.00 price target on shares of STERIS in a research report on Thursday, May 15th. Morgan Stanley increased their target price on shares of STERIS from $240.00 to $260.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Wall Street Zen upgraded shares of STERIS from a "buy" rating to a "strong-buy" rating in a report on Saturday, June 14th. Finally, JMP Securities increased their price objective on STERIS from $265.00 to $280.00 and gave the stock a "market outperform" rating in a report on Friday, May 16th. Three research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $263.83.

Insider Buying and Selling

In other STERIS news, CEO Daniel A. Carestio sold 17,626 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $242.56, for a total transaction of $4,275,362.56. Following the transaction, the chief executive officer now owns 51,385 shares in the company, valued at $12,463,945.60. This trade represents a 25.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Cary L. Majors sold 12,828 shares of the business's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $250.08, for a total transaction of $3,208,026.24. Following the completion of the sale, the senior vice president now owns 11,372 shares of the company's stock, valued at $2,843,909.76. The trade was a 53.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.07% of the company's stock.

STERIS Stock Performance

STE stock opened at $235.46 on Monday. The firm has a 50 day moving average of $234.64 and a two-hundred day moving average of $223.43. STERIS plc has a 12 month low of $200.98 and a 12 month high of $252.79. The company has a market capitalization of $23.16 billion, a price-to-earnings ratio of 37.98 and a beta of 0.94. The company has a quick ratio of 1.39, a current ratio of 1.96 and a debt-to-equity ratio of 0.29.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.47 billion. STERIS had a net margin of 11.26% and a return on equity of 14.21%. During the same period in the prior year, the company posted $2.58 earnings per share. STERIS's revenue for the quarter was up 5.7% on a year-over-year basis. As a group, equities analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Tuesday, June 10th. STERIS's payout ratio is 36.77%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.